Hepatitis D epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 2: Line 2:
{{Hepatitis D}}
{{Hepatitis D}}
{{CMG}}; {{AE}} {{VK}}
{{CMG}}; {{AE}} {{VK}}
==Overview==
HDV is rare in most [[developed country|developed countries]], and is mostly associated with [[Intravenous drug use (recreational)|intravenous drug abuse]]. However HDV is much more common in Mediterranean countries, sub-Saharan Africa, the Middle East, and countries in the northern part of South America.<ref>{{cite journal |author=Radjef N, Gordien E, Ivaniushina V, ''et al'' |title=Molecular phylogenetic analyses indicate a wide and ancient radiation of African hepatitis delta virus, suggesting a deltavirus genus of at least seven major clades |journal=J. Virol. |volume=78 |issue=5 |pages=2537–44 |year=2004 |month=March |pmid=14963156 |pmc=369207 |url=http://jvi.asm.org/cgi/pmidlookup?view=long&pmid=14963156 |doi=10.1128/JVI.78.5.2537-2544.2004}}</ref> In all, about 20 million people may be infected with HDV.<ref>{{cite journal |author=Taylor JM |title=Hepatitis delta virus |journal=Virology |volume=344 |issue=1 |pages=71–6 |year=2006 |month=January |pmid=16364738 |doi=10.1016/j.virol.2005.09.033}}</ref>


==Epidemiology and Demographics==
==Epidemiology and Demographics==

Revision as of 14:51, 8 August 2014

Hepatitis Main Page

Hepatitis D

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Hepatitis D from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Ultrasound

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Hepatitis D epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hepatitis D epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hepatitis D epidemiology and demographics

CDC on Hepatitis D epidemiology and demographics

Hepatitis D epidemiology and demographics in the news

Blogs on Hepatitis D epidemiology and demographics

Directions to Hospitals Treating Hepatitis D

Risk calculators and risk factors for Hepatitis D epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Varun Kumar, M.B.B.S. [2]

Epidemiology and Demographics

Prevalence

Worldwide, more than 15 million people have evidence of serological exposure to HDV worldwide. With the implementation of HBV vaccination programs, better education and awareness about the virus, and improving socioeconomic conditions, HDV prevalence is decreasing in many areas of the world.

Developing countries

Areas of high endemicity include Central Africa, the Horn of Africa, the Middle East, eastern and Mediterranean Europe, the Amazon Basin, and parts of Asia. HDV infection rates usually correlate with HBV endemicity except in countries such as Indonesia and Vietnam, where co-infection is uncommon. Prevalence of HDV infection ranges between provinces in China, a country with high endemicity of HBV. [1]

Two epidemiological patterns of hepatitis D infection exist: in Western Europe and North America, HDV is limited to persons exposed to blood or blood products such as with intravenous drug use. In Mediterranean countries, HDV infection is endemic among HBV carriers. In this population, the virus is transmitted by close personal contact. [2]

New foci of HDV superinfection continue to be identified in Mongolia, Greenland, Ecuador, and Venezuela.

HDV prevalence is decreasing in many areas of the world including Spain, Turkey, and Taiwan, especially in the last three decades. This has been attributed to vaccination programs for HBV, increased awareness, and an overall improvement in socioeconomic conditions. [1] It should be noted that data for HBV prevalence in developing countries is sparse.

Adapted from Center for Disease Control and Prevention(CDC)[3]

Developed Countries

HDV infection remains prevalent in France whereas in Germany and the UK, the prevalence has increased. The main factor underlying the higher prevalence in these countries is HDV infection in a younger population that has migrated from endemic regions. In Italy, HDV prevalence was previously decreasing, and has now recently plateaued.

References

  1. 1.0 1.1 Hughes SA, Wedemeyer H, Harrison PM (2011). "Hepatitis delta virus". Lancet. 378 (9785): 73–85. doi:10.1016/S0140-6736(10)61931-9. PMID 21511329.
  2. World Health Organization. Department of Communicable Disease Surveillance and Response.http://www.who.int/csr/disease/hepatitis/HepatitisD_whocdscsrncs2001_1.pdf?ua=1
  3. "Center for Disease Control and Prevention (CDC)".

Template:WH Template:WS